City Oxford Financial News

AstraZeneca has acknowledged that its Covid-19 vaccine can lead to a rare side effect known as Thrombosis with Thrombocytopenia Syndrome (TTS). This admission comes as the company faces a lawsuit alleging severe harm and deaths caused by the vaccine, according to The Telegraph. TTS is thrombosis with thrombocytopenia syndrome, which is basically a clot in blood vessels of the brain or elsewhere, along with a low platelet count. It is known to occur in very rare instances following certain types of vaccines and also from other causes. According to the WHO, adenovirus vector vaccines in particular have been rarely associated with this condition. Although COVID vaccines have prevented numerous deaths, reports of these extremely rare but potentially serious immune-mediated events have also been published in reputed journals, said Dr Rajeev Jayadevan, Co-Chairman National IMA COVID Task Force, Kerala. AstraZeneca, which collaborated with the University of Oxford to develop the vaccine, is currently embroiled in legal proceedings initiated by victims and their families. One such case involves Jamie Scott, a father of two, who took legal action after suffering a blood clot that left him unable to work. Scott claims that following his vaccination in April 2021, he developed a «blood clot and a bleed on his brain,» resulting in a lasting brain injury.

Subscribe to enjoy similar stories. As we emerge from the drowsy holidays with aspirations of being fitter and more productive, one social-media trend jumps out: How about waking up everyday at 5 a.m.? It’s true, some of the world’s top CEOs and elite athletes swear by early rising. But sleep experts say it can set you up for failure.

Subscribe to enjoy similar stories. As metaphors go, the complete closure of Europe’s busiest airport on Friday because of a fire in a suburban electricity substation is a timely one.

West Bengal Chief Minister Mamata Banerjee is likely to visit London later this month to deliver a lecture at the University of Oxford, a well-placed official said on Wednesday. Banerjee is likely to leave for London on March 21, he said. She was invited to deliver the lecture by the Pro-Vice Chancellor of the University Jonathan Michie, during the Bengal Global Business Summit in November 2023. «The CM has accepted the invitation of the University of Oxford, where she is scheduled to deliver a lecture. Her flight to London is scheduled on March 21 via Dubai,» the official said, adding that the lecture is scheduled on March 27.

OpenAI on Tuesday said it is supporting a new consortium, NextGenAI, aimed at advancing AI-assisted research at top universities. Sharing the company’s blog post, OpenAI chief Sam Altman said on X, “excited for this—advancing research and education with AI.”

UK-India Knowledge Exchange on AI driven Climate Modelling Centre and Policy Making marks a significant step in strengthening Meghalaya’s climate action by combining UK expertise to advance climate science with India’s deep regional knowledge.

Last month, former Bank of Canada governorMark Carney appeared poised to become the country’s next finance minister. Now, he has an even bigger post in his sights.

H-1B visa program has become a critical pillar for sustaining economic growth and innovation. With a predicted shortfall of 1.2 million tech workers by 2026 and nearly 1.9 million manufacturing jobs expected to remain unfilled by 2033, experts warn that reducing or eliminating H-1B visas could exacerbate these challenges.

Former Prime Minister Manmohan Singh passed away on Thursday night, shortly after being admitted to Delhi's AIIMS hospital.

University of Oxford «From Gridlock to Growth How Leadership Enables India's PRAGATI Ecosystem to Power Progress» illustrates how Prime Minister Narendra Modi's Initiatives has transformed the problems, its monitoring and resolution of various projects of the government. The report says India's PRAGATI platform offers a compelling case study of how digital governance can drive progress. Pragati was launched in 2015 by Prime Minister Narendra Modi and has become an acronym for Pro-Active Governance and Timely Implementation of projects. It has transformed the way India manages its large-scale infrastructure projects and social sector programs.

Maine is testing the legal limits of restrictions on so-called super PACs

The Diary of a CEO, Steven Bartlett writes that the first law of business and life is “filling five buckets"—knowledge, skill, network, resources and reputation. For Rudra Chatterjee, each bucket is full to the brim. The 47-year-old chairperson of Obeetee Carpets and managing director of Luxmi Tea holds an MBA from Columbia Business School and a Masters in design history from Oxford University; his network comprises advisors and friends like Nobel laureate Abhijit Banerjee and current Bangladesh PM Mohammed Yunus; and both his companies have received numerous awards.

Malaria vaccine: Ivory Coast has become the first country to deploy a malaria shot developed by Serum Institute of India Ltd., the world’s largest vaccine maker, and the University of Oxford.The first doses of the R21 immunization were administered on Monday to children in Abidjan, the commercial capital of the West African country, the developers and their partners said in a statement — the second malaria vaccine to go into use.“The new vaccine has been authorized by Ghana, Nigeria, Burkina Faso and the Central African Republic, and many others are preparing to receive shipments," they said in the statement. A total of 656,600 doses have been received, which will initially vaccinate 250,000 children from newborns to 23 months across 16 regions of Ivory Coast.The vaccine was recommended in 2023 by the World Health Organization for use in Africa for children under five years old, the age group there that bears the brunt of a disease that kills more than 600,000 people per year.

high efficacy" malaria vaccine co-developed by the Serum Institute of India (SII) and the University of Oxford was officially rolled out on Monday when Cote d'Ivoire in West Africa became the first country to begin administering R21/Matrix-M. The vaccine, which was granted World Health Organisation (WHO) approval last year, is said to have undergone a rigorous regulatory process and clinical assessment and was found to be highly effective and affordable. As a low-dose vaccine, it can be manufactured at speed and scale which is seen as critical to stemming the spread of the mosquito-borne disease. «Reducing the malaria burden is finally within sight. Today's start of the R21/Matrix-M vaccine roll-out marks a monumental milestone after years of incredible work with our partners at Oxford and Novavax,» said SII CEO Adar Poonawalla. «At Serum, we believe that it is every person's right to have access to affordable and essential disease prevention. That's why we have committed to producing 100 million doses of R21, which will protect millions of lives and alleviate the burden of this deadly disease for future generations,» he said.

Sildenafil, known by its brand name Viagra, may have benefits beyond treating erectile dysfunction. Recent research suggests it can help prevent memory-related problems by increasing cerebral blood flow and enhancing blood vessel function in those at risk of vascular dementia, a TOI report by Anuja Jaiswal stated.

Prime Minister Rishi Sunak is expected to announce a crackdown on agents marketing graduate visa schemes overseas, aiming to project a tough stance on migration before this year’s general elections. This comes after UK's university regulator warned of severe financial strains on institutions due to a decline in international student numbers. According to a Financial Times report, the new measures, anticipated to be revealed next week, will coincide with the release of quarterly migration data from the Home Office and the Office for National Statistics. The crackdown could involve mandatory registration for agents and fines for malpractice. Want to know if you qualify for immigration? Click here Sunak is also considering stricter criteria for the graduate visa scheme, potentially limiting visas to the «best and the brightest.» However, this approach has not yet been formally discussed with ministers. This proposal faces resistance from Chancellor Jeremy Hunt and Education Secretary Gillian Keegan, who worry about the financial impact on universities if international student numbers drop further.

An ongoing lawsuit in the UK over Covid vaccination has caused a global furore, including in India.UK’s The Telegraph has reported that AstraZeneca admitted in court documents that its Covid vaccinecan cause blood clots in rare instances. The pharma major is facing a class action lawsuit over claimsthat its vaccine, developed with University of Oxford, caused death and injuries. In India, where themajority of people were administered Covishield, as the AstraZeneca vaccine was known here, thenews has caused concern. Dr Shahid Jameel, virologist and research fellow at Green Templeton College,University of Oxford, tells Indulekha Aravind that there is no cause for worry as benefits far outweigh risks. But playing politics with this, he says, is both wrong and dangerous. Edited excerpts:

ANI. She said that this is a matter of investigation. "It is an old habit of the Prime Minister to take credit for any work.

News18 on Wednesday amid concerns over the rare side effects of the COVID-19 vaccine. Only seven to eight individuals out of 10 lakh who receive the Covishield vaccine face the risk of experiencing a rare side effect known as Thrombosis Thrombocytopenia Syndrome (TTS) Gangakhedkar told News18. “The risk is highest when you get the first dose.

Serum Institute of India (SII), a day after AstraZeneca, which sold the vaccine in India, admitted in court that their Covid shot can cause a rare side effect. The parents are hopeful of justice after the AstraZeneca's admission surfaced. The pharmaceutical giant is being sued in a class-action suit over claims that its Covid-19 vaccine, developed with the University of Oxford, caused death and serious injury, including TTS — thrombosis with thrombocytopenia syndrome — a serious adverse event that causes blood clots and a low blood platelet count. Venugopalan Govindan, father of Karunya, who died after taking the vaccine, said the admission by AstraZeneca is «too late» and has come after so many lives have been lost. «AstraZeneca and SII should have stopped the manufacture and supply of these vaccines when 15 European countries either suspended or age-limited these due to deaths from blood clots that happened in March 2021, within a couple of months of the rollout of the vaccine itself.»

Saurabh Bharadwaj on Tuesday said the Centre should work to urgently address the alleged side-effects of the Covidshield vaccine as millions of people in India were administered the shit during the Covid pandemic. Bharadwaj expressed concern over the alleged link between the vaccine's side-effects and a series of sudden deaths in India, claiming that Covidshield was banned in several European countries, including Germany, France, Spain, Finland, Norway and Denmark, at the beginning of 2021 due to apprehensions about its safety. UK-headquartered pharmaceutical giant AstraZeneca has admitted that in «very rare cases», its COVID-19 vaccine can cause a blood clot-related side-effect but the causal link is unknown, according to court papers being quoted in the UK media. The Daily Telegraph reported that in a legal document submitted to the High Court in London in February for a group action brought by 51 claimants, AstraZeneca admitted that the vaccine developed with the University of Oxford to protect against COVID-19 may cause Thrombosis with Thrombocytopenia Syndrome (TTS) in «very rare cases».